The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 11, 2022

Filed:

Apr. 16, 2019
Applicant:

Pierre Fabre Medicament, Boulogne-Billancourt, FR;

Inventors:

Ian Rilatt, Castres, FR;

Michel Perez, Castres, FR;

Liliane Goetsch, Ayze, FR;

Matthieu Broussas, Seyssel, FR;

Charlotte Beau-Larvor, Jonzier Epagny, FR;

Jean-François Haeuw, Beaumont, FR;

Marie Lamothe, Montredon Labessonnie, FR;

Assignee:

PIERRE FABRE MEDICAMENT, Boulogne-Billancourt, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/68 (2017.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6803 (2017.08); A61K 47/6855 (2017.08); A61K 47/6857 (2017.08); A61K 47/6859 (2017.08); A61K 47/6863 (2017.08); A61K 47/6865 (2017.08); A61K 47/6867 (2017.08); A61K 47/6869 (2017.08); A61P 35/00 (2018.01);
Abstract

The present invention relates to an antibody-drug-conjugate. From one aspect, the invention relates to an anti-body-drug-conjugate comprising an antibody capable of binding to a Target, said antibody being conjugated to at least one drag selected from derivatives of dolastatin 10 and auristatins. The invention also comprises method of treatment and the use of said anti-body-drag-conjugate for the treatment of cancer.


Find Patent Forward Citations

Loading…